P3 Health Partners Schedules Third Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Inc. has announced the scheduling of its financial results release and conference call for the third quarter of 2026.
Filings · News reference
P3 Health Partners Files Prospectus For Resale Of Up To 15,636,134 Shares By Selling Stockholders, Issuable Upon Exercise Of 15,636,134 Warrants
This prospectus relates to the proposed resale or other disposition by the Selling Stockholders (as defined herein) identified in this prospectus of up to an aggregate of 15,636,134 shares (the "Warrant Shares")
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
P3 Health Partners Filed Prospectus Covering Resale Of 15,636,134 Class A Common Shares By Selling Stockholders
Why Riot Platforms Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Riot Platforms Inc (NASDAQ: RIOT) rose sharply in pre-market trading after reporting strong second-quarter financial results.
8-K filing — P3 Health Partners Inc. (PIIIW)
Filed: 2026-09-11 AccNo: 0001832511-26-000036 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year